CRP and hepatocellular carcinoma: In conclusion, our study developed and validated a dynamic nomogram including BCLC staging, treatment modality, tumour size, and three laboratory parameters (ɣ-GGT, AFP and CRP), to predict the occurrence of MVI in patients with unresectable HCC.